In after-hours trading on Monday, Lipocine Inc. (NASDAQ: LPCN) rose 10.60% to $0.48 on no relevant news. LPCN stock lost -4.62% to finish the trading
Tag: Lipocine Inc.
Stocks to Invest
Lipocine, Inc. (LPCN) is an innovative clinical-stage biotherapeutics firm engaged in drug production for metabolic and endocrine disorders. The lead product candidates of the company